Isthmus Partners’s Stoneridge SRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-62,048
Closed -$1.23M 153
2021
Q4
$1.23M Buy
62,048
+1,830
+3% +$38.7K 0.21% 102
2021
Q3
$1.23M Buy
60,218
+12,905
+27% +$320K 0.22% 99
2021
Q2
$1.4M Buy
47,313
+1,052
+2% +$33.3K 0.25% 92
2021
Q1
$1.47M Buy
46,261
+539
+1% +$17K 0.27% 86
2020
Q4
$1.38M Sell
45,722
-622
-1% -$16.1K 0.28% 79
2020
Q3
$851K Buy
46,344
+3,387
+8% +$69.1K 0.2% 99
2020
Q2
$887K Buy
42,957
+5,931
+16% +$111K 0.22% 93
2020
Q1
$620K Sell
37,026
-1,160
-3% -$28.8K 0.19% 94
2019
Q4
$1.12M Buy
38,186
+411
+1% +$12.7K 0.26% 86
2019
Q3
$1.17M Buy
37,775
+17,345
+85% +$544K 0.28% 79
2019
Q2
$645K Buy
+20,430
New +$604K 0.15% 104

Other funds holding SRI

Isthmus Partners's SRI Position: Q1 2022 in Review

Isthmus Partners sold out of Stoneridge (SRI) in Q1 2022, closing a stake of 62,048 shares — an estimated $1.23M sold.

Isthmus Partners first reported a position in SRI in Q2 2019 and held it in 11 quarters. The position peaked at $1.47M in Q1 2021. 124 funds tracked by Wall St. Rank hold SRI as of Q1 2022.

  • Isthmus Partners reported no remaining Stoneridge position as of Q1 2022 after selling out during the quarter.
  • Isthmus Partners sold 62,048 Stoneridge shares in Q1 2022, an estimated $1.23M.
  • Isthmus Partners first reported a position in Stoneridge in Q2 2019 and held it in 11 quarters.
  • Isthmus Partners's Stoneridge position peaked at $1.47M in Q1 2021.
  • 124 funds tracked by Wall St. Rank held Stoneridge as of Q1 2022.

Based on Isthmus Partners's 13F filing for Q1 2022, filed 4 May 2022.